Results 91 to 100 of about 7,522 (217)

Double-J stenting during TURBT increases risk of metachronous upper tract urothelial carcinoma

Objective The potential impact of double-J (DJ) stenting during transurethral resection of bladder tumor (TURBT) on the occurrence of metachronous upper urinary tract urothelial carcinoma (UTUC) remains a subject of debate.
Jianfeng Guan, Guangyao Liang, Chengqiang Mo, Canhui Qu, Nanhe Lin, Yun Xie, Huanqing Wei, Zhengfeng Wu, Rui Sun   +8 more
core   +1 more source

Neuroendocrine Carcinoma of the Bladder: A Case Report

Research and Reports in Urology
Pan Gao,1,* Xinyu Li,1,* Ziqiu He,1 Yifan Xu,2 Zhi Zhang1 1Department of Urology, Second People’s Hospital of Yichang, Second People’s Hospital of China Three Gorges University, Yichang, Hubei Province, People’s Republic of China; 2Department of ...
Gao P, Li X, He Z, Xu Y, Zhang Z
doaj  

Photodynamic Therapeutic Effect during 5-Aminolevulinic Acid-Mediated Photodynamic Diagnosis-Assisted Transurethral Resection of Bladder Tumors

Advances in Urology
Background. Photodynamic diagnosis-assisted transurethral resection of bladder tumors (PDD-TURBT) enhances detection of elusive lesions compared to standard white light-transurethral resection of bladder tumors (WL-TURBT).
Nobutaka Nishimura, Makito Miyake, Sayuri Onishi, Tomomi Fujii, Tatsuki Miyamoto, Mitsuru Tomizawa, Takuto Shimizu, Yosuke Morizawa, Shunta Hori, Daisuke Gotoh, Yasushi Nakai, Kazumasa Torimoto, Nobumichi Tanaka, Kiyohide Fujimoto   +13 more
doaj   +1 more source

Protocol for pathologic examination of bladder cancer according to the updates of the 5th edition of the WHO classification (2022): biopsy and transurethral resection specimens

Patologìâ
Bladder cancer (BC) is the ninth most common malignancy in the world, and BC morbidity and mortality prevail in industrialized countries and, in particular, in Central and Eastern Europe compared to global rates.
N. S. Bondarenko, O. O. Bondarenko, M. Yu. Polion, P. O. Hrytsenko, I. S. Shponka   +4 more
doaj   +1 more source

Optimal Management for Primary High Grade Ta Bladder Cancer: Role of re-staging TURBT and Intravesical Adjuvant Therapy

ObjectiveThis study aims to investigate the impact of risk group classification, restaging transurethral resection (re-TURBT), and adjuvant treatment intensity on recurrence and progression risks in high-grade Ta tumours in patients with non-muscle ...
Dipen J. Parekh, Blachman-Braun, Ruben, Ruben Blachman‐Braun, Ajami, Tarek, Hougen, Helen Y., Punnen, Sanoj, Yuval Avda, Nahar, Bruno, Avda, Yuval, Sunwoo Han, Sanoj Punnen, Reis, Isildinha M., Ritch, Chad R., Tarek Ajami, Bruno Nahar, Mark L. Gonzalgo, Han, Sunwoo, Isildinha M. Reis, Helen Y. Hougen, Chad R. Ritch, Gonzalgo, Mark L., Parekh, Dipen J.   +21 more
core   +1 more source

Analysis of risk factors for ureteral stricture and tumor recurrence after transurethral resection of bladder tumor in paraureteral bladder cancer

Frontiers in Surgery
BackgroundThis study explores the risk factors for ureteral stricture and tumor recurrence after transurethral resection of bladder tumor (TURBT) in patients with paraureteral bladder cancer, aiming to provide references for clinicians in their treatment
Rui Meng, Yu Han, Zhipeng Zhai
doaj   +1 more source

ERAS for Ambulatory TURBT: Enhancing Bladder Cancer Care (EMBRACE) randomised controlled trial protocol

Introduction Transurethral resection of bladder tumour (TURBT) is one of the more common procedures performed by urologists. It is often described as an ‘incision-free’ and ‘well-tolerated’ operation.
Michael E Rezaee, Armine K Smith, Sunil H Patel, Bruce J Trock, The-Hung Edward Nguyen, Noah M Hahn, Katherine M Mahon, Max Kates   +7 more
core   +1 more source

Routine preoperative group and save for TURP and TURBT – need and cost effectiveness

, 2017
Introduction: Standard practice in our unit is to take a group and save (G+S) blood sample for all patients undergoing a transurethral resection of prostate (TURP) and transurethral resection of bladder tumour (TURBT). Modern studies show the transfusion
Hazel Smith, Justyna Szczachor, Sarfraz Ahmad, Rachel Falconer   +3 more
core   +1 more source

Presence of variant histology (VarHst) in transurethral resection of bladder tumor (TURBT) biopsies and its prognostic significance on pathologic complete response (pCR) rates to neoadjuvant chemotherapy (neo-CTx).

, 2013
295 Background: Randomized phase III clinical trial data (S8710) supports an overall survival (OS) advantage with neo-CTx for muscle-invasive urothelial carcinoma (miUC) patients (pts) prior to cystectomy. Recent S8710 subset analyses have demonstrated
Derek E. Thomas, Kevin Rice, Dylan M. Cregar, Liang Cheng, Stephen Beck, Timothy A. Masterson, Noah M. Hahn, Richard Foster, Charles R. Powell, Paul Johnston, Michael O. Koch, Cindy Franklin, Richard Bihrle, David A. Grignon, Angela D. Reed, Marietta L. Moore, Jose Alexandre Pedrosa, Thomas A. Gardner, Chandru Sundaram   +18 more
core   +1 more source

Rationale of restaging transurethral resection of bladder tumor in patients with nonmuscle invasive bladder cancer in the current era

Urology Annals
Background: We present retrospective data of patients with nonmuscle invasive bladder cancer (NMIBC) who underwent restaging transurethral resection of bladder tumor (Re-TURBT) at a tertiary care center.
Amit Sharma, R. T. Raghavendra, Deepak Biswal, Pradhuman Yadav, Saryu Goel, Satyadeo Sharma   +5 more
doaj   +1 more source